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Abstract. Accurate self-monitoring of blood glucose is the key to an effective and safe intensive insulin therapy. Indeed, most
insulin dosing decisions are made based on the blood glucose values obtained from home glucose meters, in particular for those
using diet planning and carbohydrate counting. Patients on that therapeutic regimen depend not only on their ability to accurately
estimate the carbohydrate content of each meal but also on the accuracy of the glucose meter being used. Therefore, in order to
avoid postprandial hypoglycemia and hyperglycemia, it is of great importance to realize how important is the accuracy of blood
glucose meters according to the particular characteristics of each patient. In this regard, we propose an analytic method to find the
limits of the blood glucose meters accuracy according to the insulin-to-carb ratio, the insulin sensitivity factor and the ability of
each patient to estimate the carbohydrate content of each meal.
INTRODUCTION
Self-Monitoring of Blood Glucose (SMBG) is the mainstay of proper diabetes management, supporting tight blood
glucose control in patients on intensive insulin regimens, e.g., patients using diet planning and carbohydrate counting.
However, to be useful and safe SMBG needs to be accurate. The accuracy of SMBG systems relies on several factors,
being the accuracy of the blood glucose meters one of the most important [1]. As reported by Ekhlaspour et al in [2],
the accuracy of commercially available blood glucose meters varies significantly. Regarding this study, 17 glucose
meters were tested and it was found that their mean absolute relative difference (MARD) range from 5.6% to 20.8%.
Inaccurate blood glucose measurements may lead to incorrect dosing calculations which may result in dangerous
variations of insulin doses and negatively influence glycemic control [1, 3]. Indeed, Campos-Na´n˜ez et al conducted
a 30-day in-silico study and found that blood meters accuracy clearly affect the glycemic control in type 1 diabetes
patients. Moreover, the study shows that the meters’ accuracy has a significant impact not only on the occurrence of
severe hypoglycemic events but also on long-term average glycemia (HbA1c) [4].
In this context, it is of great importance to choose the correct blood glucose meter taking into account the
particular characteristics and glycemic goals of each patient. Therefore, we propose an analytic method to find the
limits of the blood glucose meters accuracy that considers the ability of each patient to estimate the carbohydrate
content of each meal1 along with its’ insulin-to-carb ratio and insulin sensitivity factor.
1The ability of each patient to accurately estimate the carbohydrate content of each meal could be quantified considering the average absolute
error committed by the patient while evaluating a set of N meals, by: ΔCHO =
∑N
i=1
∣∣∣CHOicorrect −CHOiestimate
∣∣∣ /N, where the CHOicorrect and the
CHOiestimate are, respectively, the correct and estimate values of the carbohydrate content of i-meal, i = 1, ...,N.
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MATHEMATICAL METHODS
The equation
B =
(CHO
ICR
+
G −GT
IS F
)
K − IOB (1)
allows patients using carbohydrate counting to calculate the insulin bolus (i.e., prandial and correctional insulin) for
each meal, according to the carbohydrates planned to be consumed in that meal (CHO), the insulin-to-carb ratio
(ICR), the preprandial blood glucose target (GT ), the preprandial blood glucose value (G), the insulin sensitivity
factor (IS F), the physiologic status of the patient represented by K, and the insulin remaining active from the last
bolus (IOB, Insulin-on-Board) [5, 6]. In the subsequent analysis, we will consider K = 1 (i.e., the impact of illness,
physical activity or medication on insulin and glucose metabolism of patients will not be addressed in this study) and
IOB = 0 (i.e., it will be considered that the time between meals is larger than the duration of the insulin action, and
there is no insulin stacking). Moreover, we also assume that patient’s ICR and IS F are physiologically appropriate.
Let’s consider CHO = ˆCHO±ΔCHO and G = Gˆ±ΔG to be variables of Equation 1, where ˆCHO is an estimate
of CHO with an absolute error ΔCHO > 0, and Gˆ is an estimate of G with an absolute error ΔG > 0. The remaining
variables of Equation 1 are considered to be exact values. In such conditions, the absolute error of B is ΔB =
∣∣∣B − Bˆ∣∣∣,
where: B = CHO/ICR+ (G−GT )/IS F and Bˆ = ˆCHO/ICR+ (Gˆ−GT )/IS F (n.b., ICR and IS F are positive values).
Therefore, we have:
ΔB =
∣∣∣∣∣∣
CHO − ˆCHO
ICR
+
G − Gˆ
IS F
∣∣∣∣∣∣ ≤
ΔCHO
ICR
+
ΔG
IS F
.
The bolus’ absolute error, ΔB, will perform as an unplanned and inappropriate correction bolus, with the
consequent undesired effect on the patient’s postprandial glycemia (Gpostprandial) given by:
ΔGpostprandial = ΔB · IS F ≤ IS FICRΔCHO + ΔG,
where ΔGpostprandial is the variation on the patient postprandial blood glucose.
By denoting the hyperglycemia and hypoglycemia limits as GHyper and GHypo, respectively, it is possible to
conclude that the maximum value of ΔGpostprandial allowed, in order to avoid hyperglycemia and hypoglycemia
episodes, is given by min
{
GHyper −GT ,GT −GHypo
}
(n.b., the function min{·} returns the minimum value of a set
of elements) and, therefore, it is sufficient to satisfy the following condition to avoid them:
ΔCHO ≤ ICR
IS F
(
min
{
GHyper −GT ,GT −GHypo
}
− ΔG
)
. (2)
Equation 2 shows that the sufficient limits of accurate carbohydrate counting, in order to avoid dysglycemia,
depend not only on each patient data but also on the accuracy of the blood glucose meter being used. Therefore,
taking into account the ability of each patient to correctly estimate the carbohydrate content of each meal, along
with it’s IS F, ICR, and glycemic targets, the blood glucose meter absolute error, ΔG, should satisfy the following
conditions:
ΔG ≤ min
{
GHyper −GT ,GT −GHypo
}
− IS F
ICR
ΔCHO
and
ΔCHO ≤ ICR
IS F
(
min
{
GHyper −GT ,GT −GHypo
}
− ΔG
)
.
DISCUSSION
To assess and discuss the implications of the proposed method let’s consider a hypothetical patient of 75 kg body
weight, consuming a total of 50U of insulin each day, having a preprandial glucose target of GT = 110mg/dL, and
the following glycemic thresholds for hyperglycemia and hypoglycemia, respectively: GHyper = 150mg/dL, GHypo =
70mg/dL. Suppose, without loss of generality, that the ICR and IS F for this patient are calculated according to
the recommendations of the American Association of Clinical Endocrinologists/American College of Endocrinology
250010-2
(AACE/ACE) [7], using the following rules: ICR = 450/TDD and IS F = 1700/TDD, where TDD is the Total Daily
Dose of insulin that, in this case, is equal to 50U. Therefore, under these assumptions, the patient’s ICR and IS F are
9 g/U and 34mg/dL/U, respectively. Finally, this patient is able to estimate the carbohydrate content of each meal with
an average absolute error of 10 g (i.e., ΔCHO = 10 g).
According to Equation 2, the maximum absolute error allowed while estimating the carbohydrate content of each
meal depends on the meter accuracy and on the patient data, as shown Figure 1. Let us consider first the use of an
ideal blood glucose meter, i.e., having no error. In that case, the maximum admissible absolute error while estimating
the carbohydrates is given by ΔCHOmax = 9 × 40/34 ≈ 10.59 g. Hence, since ΔCHO ≤ ΔCHOmax, the risk of the
patient facing dysglycemic events is reduced. However, such an ideal meter does not exist. Moreover, the accuracy of
the blood glucose meters available on the market varies significantly, as can be seen in Table 1.
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FIGURE 1. a) The maximum admissible absolute error of CHO as a function of the glucose meter accuracy and the ICR/IS F
ratio; b) The maximum admissible absolute error of CHO as a function of the glucose meter accuracy for ICR/IS F=450/1700.
Taking into account the accuracy of the blood glucose meters, the value of ΔCHOmax could be significantly
smaller. Table 1 shows the value of ΔCHOmax for several blood glucose meters and, makes clear that none of them
fits into the diabetes management strategy of this patient. Therefore, this patient must improve their carbohydrates
counting skills or change their glycemic targets. As an example, if the patient glycemic goals change to GT =
120mg/dL, GHyper = 170mg/dL, and GHypo = 70mg/dL, it will be safe to use any of the first four blood glucose
meters listed in Table 1, under the range 20 ≤ BS < 180.
Therefore, the accuracy of the blood glucose meters is a determinant factor for a proper glycemic control and
must be taken into account while fitting the diabetes management strategy of each patient.
CONCLUSION
Patients with diabetes make their insulin dosing decisions based on the glycemic values obtained from home glucose
meters. Indeed, patients on intensive insulin regimens, particularly those using meal planning and carbohydrate
counting, heavily depend not only on their ability to accurately estimate the carbohydrate content of each meal but also
on the accuracy of the blood glucose meters to achieve a rigorous glycemic control. Therefore, to avoid dysglycemic
events, it is fundamental to understand the impact of the blood glucose meters accuracy on the insulin bolus. To
that end, we propose an analytic method to find the limits of the blood glucose meters accuracy according to the
insulin-to-carb ratio, the insulin sensitivity factor and the ability of each patient to estimate the carbohydrate content
of each meal. By using the proposed method, healthcare professionals are able to make informed decisions about the
best blood glucose meter for each patient according to their particular characteristics. Moreover, this method allows
healthcare professionals to optimize the glycemic goals of each patient according to their characteristics and meter
accuracy in order to lessen the risk of hypoglycemic and hyperglycemic episodes.
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TABLE 1. The maximum of the glucose meter absolute error (ΔGmax), and the maximum admissible
absolute error of carbohydrate counting (ΔCHOmax) for each glucose meter. The value of ΔGmax
was estimated according to the data reported in Table 2 of [2], for different glucose ranges as:
ΔGmax ≈ MARD×max {BS in the range} /100 (n.b., BS stands for Blood Sugar). On its turn, ΔCHOmax
was calculated according to Equation 2, taking into account the ΔGmax of each glucose meter, and the
specific characteristics of the patient being considered.
Blood Sugar Ranges (mg/dL)
20 ≤ BS < 70 70 ≤ BS < 180 180 ≤ BS < 440
Blood Glucose Meter ΔGmax ΔCHOmax ΔGmax ΔCHOmax ΔGmax ΔCHOmax
# 1 Contour Next 6.23 8.94 8.64 8.30 23.76 4.30
# 2 StatStrip Xpress 7.77 8.53 8.82 8.25 26.40 3.60
# 3 OneTouch VeriolQ 6.93 8.75 11.34 7.59 29.92 2.67
# 4 Accu-Chek Nano 8.12 8.44 12.06 7.40 29.92 2.67
# 5 FreeStyle Freedom Lite 10.78 7.73 13.14 7.11 27.28 3.37
# 6 Accu-Chek Aviva Plus 8.47 8.35 13.14 7.11 30.36 2.55
# 7 FreeStyle Lite 11.62 7.51 14.22 6.82 29.92 2.67
# 8 Nova Max 18.90 5.59 16.02 6.35 30.36 2.55
# 9 TRUEresult 9.24 8.14 23.04 4.49 57.64 *
# 10 HemoCue Glucose 201 13.93 6.90 20.88 5.06 55.44 *
# 11 OneTouch Ultra2 21.21 4.97 28.26 3.11 42.68 *
# 12 ReliOn Prime 11.34 7.59 20.52 5.16 66.44 *
# 13 BREEZE R©2 17.99 5.83 23.94 4.25 65.56 *
# 14 ReliOn Micro 20.93 5.05 25.56 3.82 62.04 *
# 15 AgaMatrix PRESTO 27.44 3.32 38.16 0.49 43.12 *
# 16 AgaMatrix JAZZ 26.60 3.55 40.14 * 46.20 *
# 17 SideKick 22.19 4.71 30.06 2.63 89.76 *
* As ΔGmax > min
{
GHyper −GT ,GT −GHypo
}
, Equation 2 does not apply. In this case, even with ΔCHO = 0, the patient
may have dysglycemic episodes.
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